Press Releases

BrightFocus Honors the Life of John Q. Trojanowski, MD, PhD

Proposed Federal Rule Would Create Chilling Effect on Future Research

The FDA has approved a new treatment for “wet” AMD.  Known as Vabysmo™, it can extend time between treatments for up to four months.

BrightFocus Foundation, a nonprofit organization funding scientific research to end diseases of mind and sight, Alzheimer’s, macular degeneration and glaucoma, announced a special program, Brain Info Live: A Fireside Chat for Caregivers with Richard Lui.